Registered Malawi · PMRA

EROSTIN 10 10MG TABLET

EBASTIN

PMPB/PL106/33 TABLET respiratory system

What it does

Ebastine is an antihistamine used to relieve allergy symptoms.

Commonly used for: allergic rhinitis (hay fever), urticaria (hives)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL106/33
Registration date
31/01/2014
Expiry date
31/03/2025
Status
Registered
Active ingredient
EBASTIN
Dosage form
TABLET
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
R06AX - Other antihistamines for systemic use
Drug group
RESPIRATORY SYSTEM
RxNorm RxCUI
23796
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-29 04:33:03

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ebastine is an antihistamine used to relieve allergy symptoms.

What it treats

  • allergic rhinitis (hay fever)
  • urticaria (hives)

How it works

Ebastine helps reduce allergy symptoms by blocking the action of histamine, a substance in the body that causes allergic reactions.

Who it's for

Ebastine is suitable for adults and children over 12 years who experience allergies.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: ebastin

BNF-referenced

Ebastine is a second-generation antihistamine primarily used for the relief of symptoms associated with allergic conditions. It is effective in managing allergic rhinitis and urticaria, providing symptomatic relief without the sedative effects commonly associated with first-generation antihistamines.

Indications

  • Allergic rhinitis
  • Urticaria

Dosage

Children: Refer to BNF for Children for specific dosing guidelines.

Adults: Refer to BNF for specific dosing guidelines.

Mechanism of action

Ebastine functions as a selective antagonist of the histamine H1 receptor, effectively blocking the action of histamine, a key mediator in allergic responses. This action leads to a decrease in symptoms such as itching, sneezing, and nasal congestion associated with allergies.

Pharmacodynamics

The pharmacodynamic properties of ebastine include its ability to selectively inhibit the binding of histamine to H1 receptors, thus preventing the activation of downstream signaling pathways that contribute to allergic symptoms. This selectivity also results in a lower incidence of central nervous system side effects compared to first-generation antihistamines.

Pharmacokinetics

Ebastine is well absorbed following oral administration, with peak plasma concentrations typically occurring within 1 to 2 hours. It undergoes extensive first-pass metabolism, primarily to its active metabolite, carebastine, which contributes to its antihistaminic effect. The elimination half-life of ebastine is approximately 15 hours, allowing for once-daily dosing.

Adverse effects

  • Drowsiness
  • Headache
  • Dry mouth
  • Fatigue
  • Nausea

Precautions

  • Caution in patients with liver impairment
  • Use with caution in patients with a history of seizures

Pregnancy

There is limited data on the use of ebastine in pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether ebastine is excreted in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Tablets
  • Oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: ebastin

PubChem CID 3191

Molecular formula: C32H39NO2

Mechanism of action

Ebastine is a second-generation antihistamine that acts as a selective histamine H1-receptor antagonist to relieve allergic symptoms.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.